New opportunities in metabolic disease management with sustained drug delivery

One of the greatest opportunities we see for both our pharmaceutical partners and patients is the ability to improve the management of metabolic diseases like diabetes. Our biocompatible materials for drug delivery can enable long-duration therapies – with reduced dosing frequency and potentially increased patient adherence.

We work with partners worldwide across the continuum of healthcare to create unique drug delivery solutions for metabolic disease that bring progress to life for patients  



15+ years of experience in sustained drug delivery applications.



30+ years of experience working with the world’s leading pharmaceutical companies.



150+ years of combined scientific discovery and heritage as part of dsm-firmenich.

Creating next-generation therapies with TheraPEA™

Our TheraPEA™ polyester amide platform is unlocking entirely new therapeutic opportunities for the pharmaceutical industry through its ability to achieve multi-month, controlled drug release. 

This highly tunable biomaterial has a zero-order degradation profile and good correlation in-vitro and in-vivo up to 180 days. Furthermore, the unique chemistry of TheraPEA™ changes the game even further through its compatibility with a wide range of challenging Active Pharmaceutical Ingredients.

By developing customized drug delivery solutions with our partners in this way, we can enable longer duration therapies for patients with the potential to increase therapy adherence  – and allow for improved clinical outcomes, better healthcare economics and significantly less medical waste.

Learn more about our drug delivery solutions.

Discover our drug delivery solutions for metabolic disease management

In the treatment of diabetes (Type II) and obesity, our team can work with you to create long-acting therapies in both implantables and long-acting injectables. However, the potential benefits of our TheraPEA™ solution extends even further. 

For example, integrating this unique biomaterial into new pharmaceutical formulations unlocks the potential to increase IP protection and extend the lifetime of branded sales.

Our biomaterial solutions for diabetes management

Our medical grade biomaterials contribute to the increased reliability and accuracy of insulin delivery solutions, including Glucose Monitoring Devices.

Visit our Knowledge Center

At DSM Biomedical we’ve built a wealth of knowledge in metabolic disease management.

Technical Resources

Looking for more information on how our drug delivery solutions for metabolic disease management can help you tackle unmet needs?

Overcoming limitations in sustained release drug delivery

TheraPEA™ Biodegradable Polyester Amide Platform Brochure

Our team is here and ready to support you

Discover how we can partner with you to enable long-acting implantable and injectable drug therapies for metabolic disease management.

Need expert assistance? 

Our team is here to help.                                                                             

This site uses cookies to store information on your computer.

Learn more